Collectively, these data indicate that coexpression of E-cadherin with pGSK3βS9 and COX-2 expression is observed in vivo in a subset of BCs including metastatic PDXs and could be indicative of aggressive tumor biology. This evidence concerns the gene PTGS2 and neoplasm.